GeneXpert MTB/RIF version G4 for identification of rifampin-resistant tuberculosis in a programmatic setting.
J Clin Microbiol
; 52(2): 635-7, 2014 Feb.
Article
in En
| MEDLINE
| ID: mdl-24478501
ABSTRACT
A recent Cochrane review estimated GeneXpert MTB/RIF specificity for rifampin resistance as 98% (95% confidence interval [CI], 97 to 99), based on results from earlier test versions. The measured positive predictive value of the new generation test from programmatic implementation in Cape Town, South Africa, was 99.5% (95% CI, 98.5 to 100), confirming excellent specificity.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rifampin
/
Bacteriological Techniques
/
Tuberculosis, Multidrug-Resistant
/
Molecular Diagnostic Techniques
/
Drug Resistance, Bacterial
/
Mycobacterium tuberculosis
/
Antitubercular Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Africa
Language:
En
Journal:
J Clin Microbiol
Year:
2014
Document type:
Article
Affiliation country:
Sudáfrica